At Umoja, we aim to continuously create an environment where everyone can feel included and represented, and bring their full selves to our lofty goals of transforming the field of immunotherapy. During Pride Month this year, we honored and celebrated our LGBTQIA+ colleagues and allies along with their contributions to advance our science. Thank you to our YOUmoja committee and both our sites in Colorado and Washington for organizing such great events like this year's Pride celebrations! 🌈 🧪 #PrideMonth #LoveIsLove #LifeSciences
Umoja Biopharma
Pharmaceutical Manufacturing
Seattle, WA 15,341 followers
Next Generation Immunotherapies
About us
Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer. We envision a world where all patients with cancer have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Seattle, WA
- Type
- Privately Held
- Founded
- 2019
Locations
-
Primary
1920 Terry Avenue
Seattle, WA 98101, US
Employees at Umoja Biopharma
Updates
-
Umoja Biopharma reposted this
We are honored to announce the publication of the first successful in vivo CAR T-cell non-human primate data in Blood, the flagship journal of American Society of Hematology, stemming from our pre-clinical investigations of our proprietary VivoVec™ particles. Learn more about this continued validation of our platform and how our science at Umoja could be laying the groundwork for a paradigm shift in the field of CAR T-cell therapies:
-
We are honored to announce the publication of the first successful in vivo CAR T-cell non-human primate data in Blood, the flagship journal of American Society of Hematology, stemming from our pre-clinical investigations of our proprietary VivoVec™ particles. Learn more about this continued validation of our platform and how our science at Umoja could be laying the groundwork for a paradigm shift in the field of CAR T-cell therapies:
Umoja Biopharma Announces Publication in Blood Highlighting Successful Generation of In Vivo CAR T-cells in Non-Human Primate Modeling
https://www.umoja-biopharma.com
-
In our latest blog post, our CEO, Andy Scharenberg reflects on his experience as a panelist at #SXSW2024 and details his goal of advancing practice-changing #CellTherapies. Read more about his panel, “From Adversary to Ally: Reimagining Viruses As Medicines” here: https://lnkd.in/g9J8RZFB #MedicinesGoViral
-
Here at Umoja, our world-class team is united by our shared goal of unlocking the true potential of #CART cell therapies. We're recognizing #WorldBloodCancerDay by sharing our commitment to extending the benefits of #immunotherapy to every patient bearing the burden of #cancer.
-
We're proud to announce that Umoja scientist Ashley Yingst abstract on Synthetic Receptor Enabled Differentiation (ShRED) received the ISCT, International Society for Cell & Gene Therapy Stem Cell Engineering Abstract Award. This recognition reflects Umoja’s commitment to advancing "off-the-shelf" #Immunotherapies. More on this prestigious award: https://bit.ly/3y8QPak
-
-
Our CEO, Andy Scharenberg, MD was recently featured on an episode of the Talking Biotech podcast with Dr. Kevin Folta! Listen to the episode to learn how Umoja is engineering #CARTcells #InVivo to create more effective #CellTherapies: https://lnkd.in/gMADtcUJ
-
-
Umoja will present at the 27th American Society of Gene & Cell Therapy Annual Meeting! We are excited to attend alongside other industry leaders and present pharmacokinetics data regarding our #VivoVec platform. Read the abstract here: https://bit.ly/3JJlCgp #ASGCT2024
-
-
Earlier this month, we had the honor of touring another group of #biotech’s next generation of ambitious scientists and engineers around The CLIMB as part of our continued engagement and partnership with the Colorado BioScience Institute mentorship program. Thank you to Chelsea Johansen, Jillian Collins, Samuel Saccomano, and Tyler Sodia for coming to learn about how we’re bringing Umoja’s #CGT vision to life at The CLIMB to enable bringing innovative products to patients.
-
-
For #NationalVolunteerWeek, we're highlighting the great work Umojians are doing to shine light on #STEM careers all over Seattle and in Colorado. Thank you, Alessandra Sullivan, for your work connecting Umoja with young talent so we can guide them to a new world of opportunity. #GlobalVolunteerMonth